Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bg Medicine (BGMD)
OTHER OTC:BGMD
Holding BGMD?
Track your performance easily
BGMD Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume5.91K
Average Volume (3M)9.90K
Market Cap
$11.00
Enterprise ValueN/A
Total Cash (Recent Filing)$23.87M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-47.49
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding11,374,000
10 Day Avg. Volume8,500
30 Day Avg. Volume9,898
Standard Deviation45.08
R-Squared0.01
Alpha5.38
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.39
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BGMD FAQ
What was Bg Medicine’s price range in the past 12 months?
Currently, no data Available
What is Bg Medicine’s market cap?
Bg Medicine’s market cap is $11.00.
When is Bg Medicine’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bg Medicine’s earnings last quarter?
Currently, no data Available
Is Bg Medicine overvalued?
According to Wall Street analysts Bg Medicine’s price is currently Overvalued.
Does Bg Medicine pay dividends?
Bg Medicine does not currently pay dividends.
What is Bg Medicine’s EPS estimate?
Bg Medicine’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bg Medicine have?
Bg Medicine has 11,374,000 shares outstanding.
What happened to Bg Medicine’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bg Medicine?
Currently, no hedge funds are holding shares in BGMD
---
Company Description
Bg Medicine
BG Medicine, Inc. engages in developing and delivering innovative solutions for healthcare providers that provide insight and transform the clinical care of heart failure and related disorders. It distributes products such as BGM Galectin-3 to clinical laboratories, hospitals and health care provider. The company was founded in February 2000 and is headquartered in Foxboro, MA.
---
---